ELDN
Eledon Pharmaceuticals Inc
2.70$
-1.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +31.0% | -35.8% | +49.1% | -4.9% | +54.8% | -9.1% | -10.2% | -10.4% | +30.2% | -13.2% | -14.0% | |
| – | -10.9% | -14.5% | +81.8% | -6.5% | +76.3% | -11.1% | -12.8% | -13.6% | +40.9% | -16.3% | -18.0% | |
| – | +25.8% | +22.6% | +360.5% | -74.1% | +204.4% | -58.7% | -32.4% | -36.1% | +521.6% | -73.0% | +10.6% | |
| – | -14.3% | -16.1% | +95.1% | -6.5% | +79.3% | -10.9% | -13.9% | -13.2% | +42.8% | -16.7% | -20.1% | |
| – | – | – | – | – | – | – | -7.4% | +6.8% | -31.7% | +13.4% | -26.8% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +797.2% | -85.9% | +2,050.1% | -70.1% | +53.9% | -21.2% | -16.8% | +143.0% | -7.0% | -47.4% | +17.0% | |
| – | +34.4% | +9.0% | +41.9% | +107.3% | -7.3% | -20.7% | +49.4% | +4.2% | +28.3% | -26.6% | -12.4% | |
| – | -3.3% | -25.8% | -5.3% | -30.9% | +68.8% | +3.5% | +3.4% | +3.0% | +3.5% | +3.1% | +3.3% | |
| – | +108.0% | +92.8% | +15.2% | +172.8% | -0.5% | -50.3% | +101.0% | -20.6% | -21.6% | +81.6% | -51.2% | |
| – | -8.7% | -10.3% | -111.4% | – | +55.3% | -3.0% | -7.5% | -66.7% | +129.3% | +23.9% | -28.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -19.2% | +23.9% | +41.0% | +31.2% | +7.8% | +29.0% | +0.0% | +0.0% | -2.2% | +49.0% | +1.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.